Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Hedy Kindler

Concepts (734)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mesothelioma
92
2022
296
18.290
Why?
Pleural Neoplasms
58
2021
183
12.030
Why?
Pancreatic Neoplasms
53
2022
681
9.500
Why?
Antineoplastic Combined Chemotherapy Protocols
68
2022
2356
6.320
Why?
Deoxycytidine
38
2020
242
5.020
Why?
Adenocarcinoma
33
2022
1206
4.940
Why?
Lung Neoplasms
52
2022
2156
4.340
Why?
Antineoplastic Agents
40
2020
2379
3.180
Why?
Antimetabolites, Antineoplastic
21
2018
251
2.720
Why?
Phthalazines
6
2022
32
2.680
Why?
Neoplasm Staging
44
2021
1953
2.460
Why?
Peritoneal Neoplasms
11
2022
182
2.310
Why?
Aged
149
2022
18818
2.300
Why?
Aged, 80 and over
96
2021
6681
2.260
Why?
Middle Aged
149
2022
25921
1.990
Why?
Antibodies, Monoclonal, Humanized
21
2021
966
1.950
Why?
Colonic Neoplasms
15
2022
565
1.860
Why?
Gastrointestinal Neoplasms
4
2020
107
1.860
Why?
Humans
245
2022
85377
1.860
Why?
Antibodies, Monoclonal
17
2021
1534
1.810
Why?
Glutamates
15
2014
94
1.700
Why?
Germ-Line Mutation
12
2022
301
1.660
Why?
Male
155
2022
42567
1.660
Why?
Neoplasm Recurrence, Local
20
2022
1205
1.650
Why?
Female
157
2022
45502
1.650
Why?
Stomach Neoplasms
9
2020
264
1.640
Why?
Pyridines
7
2016
313
1.610
Why?
Fluorouracil
17
2020
567
1.600
Why?
Guanine
15
2014
208
1.600
Why?
Maintenance Chemotherapy
2
2020
77
1.540
Why?
Treatment Outcome
61
2021
8050
1.540
Why?
Adult
107
2022
26383
1.450
Why?
Carcinoma, Pancreatic Ductal
6
2018
97
1.430
Why?
Disease-Free Survival
26
2022
1209
1.420
Why?
Survival Rate
31
2022
1936
1.400
Why?
Piperazines
7
2019
273
1.360
Why?
Colorectal Neoplasms
15
2018
888
1.340
Why?
Protein Kinase Inhibitors
9
2016
574
1.250
Why?
Cisplatin
19
2021
585
1.190
Why?
Esophageal Neoplasms
6
2020
349
1.190
Why?
Leucovorin
11
2020
220
1.160
Why?
Kaplan-Meier Estimate
19
2020
907
1.100
Why?
Neoplasms
23
2022
2764
1.080
Why?
Immunoconjugates
2
2022
114
1.060
Why?
Quinazolines
7
2012
220
1.050
Why?
Camptothecin
9
2017
196
1.020
Why?
Glucuronosyltransferase
3
2020
188
1.010
Why?
Survival Analysis
24
2020
1602
0.970
Why?
Pyrimidines
7
2016
403
0.900
Why?
Liver Neoplasms
11
2011
651
0.890
Why?
Genes, BRCA2
2
2019
149
0.860
Why?
Genes, BRCA1
2
2019
187
0.850
Why?
Diet
7
2022
467
0.850
Why?
BRCA1 Protein
5
2020
182
0.840
Why?
Pneumonectomy
7
2019
192
0.830
Why?
Prognosis
26
2022
3751
0.810
Why?
Molecular Targeted Therapy
2
2020
279
0.800
Why?
Organoplatinum Compounds
6
2017
99
0.760
Why?
Clinical Trials as Topic
16
2019
1221
0.720
Why?
Hedgehog Proteins
2
2016
90
0.720
Why?
Angiogenesis Inhibitors
6
2021
294
0.720
Why?
Vascular Endothelial Growth Factor A
8
2021
391
0.710
Why?
Drug Administration Schedule
14
2019
973
0.710
Why?
BRCA2 Protein
4
2020
138
0.680
Why?
Biliary Tract Neoplasms
3
2019
32
0.660
Why?
Ovarian Neoplasms
2
2022
691
0.660
Why?
Double-Blind Method
13
2019
1915
0.660
Why?
GPI-Linked Proteins
5
2020
55
0.660
Why?
Chemotherapy, Adjuvant
10
2022
472
0.650
Why?
Tomography, X-Ray Computed
14
2022
2601
0.640
Why?
Rare Diseases
1
2016
59
0.620
Why?
Neoplasm Metastasis
15
2020
1063
0.620
Why?
Quality of Life
10
2022
1416
0.610
Why?
Neoadjuvant Therapy
6
2018
286
0.600
Why?
Folic Acid Antagonists
4
2008
20
0.590
Why?
Anilides
1
2015
48
0.580
Why?
Gallbladder Neoplasms
2
2005
28
0.580
Why?
Asbestos
2
2013
22
0.570
Why?
Radiation Injuries
6
1999
159
0.560
Why?
Combined Modality Therapy
11
2021
1694
0.550
Why?
Bile Duct Neoplasms
2
2005
70
0.550
Why?
Disease Progression
11
2022
1490
0.550
Why?
Germ Cells
3
2022
111
0.540
Why?
Follow-Up Studies
22
2022
3894
0.530
Why?
Salvage Therapy
3
2010
225
0.530
Why?
Thiazoles
2
2012
131
0.520
Why?
Pyrazines
6
2019
86
0.520
Why?
Maximum Tolerated Dose
14
2021
272
0.510
Why?
Maytansine
3
2022
8
0.510
Why?
Benzenesulfonates
2
2010
64
0.510
Why?
Radioactive Hazard Release
4
1999
8
0.470
Why?
Epothilones
2
2009
13
0.460
Why?
Pleura
4
2018
31
0.450
Why?
Prospective Studies
20
2022
4178
0.440
Why?
Imidazoles
2
2014
170
0.430
Why?
User-Computer Interface
6
1999
190
0.430
Why?
Indazoles
1
2011
71
0.420
Why?
Medical Oncology
3
2018
338
0.420
Why?
Neutropenia
9
2019
223
0.420
Why?
Dose-Response Relationship, Drug
14
2019
2104
0.410
Why?
Platelet-Derived Growth Factor
3
2011
68
0.400
Why?
Diagnostic Imaging
2
2019
456
0.390
Why?
Child Abuse
1
2010
87
0.390
Why?
Hyperinsulinism
2
2020
50
0.390
Why?
Preoperative Care
3
2018
417
0.380
Why?
Pleural Effusion, Malignant
1
2009
14
0.380
Why?
Signal Transduction
5
2016
3337
0.370
Why?
Infusions, Intravenous
10
2009
448
0.370
Why?
Ubiquitin Thiolesterase
6
2022
57
0.370
Why?
Carboplatin
6
2021
274
0.370
Why?
Paclitaxel
6
2021
464
0.370
Why?
Purine-Nucleoside Phosphorylase
1
2008
24
0.360
Why?
Arsenicals
1
2008
42
0.360
Why?
Oxides
1
2008
49
0.360
Why?
Mass Screening
2
2011
659
0.360
Why?
Placebos
4
2015
233
0.360
Why?
Benzamides
6
2019
224
0.360
Why?
Polymorphism, Single Nucleotide
5
2021
2349
0.360
Why?
Retrospective Studies
14
2020
7985
0.360
Why?
Expert Systems
3
1998
18
0.360
Why?
Antineoplastic Agents, Phytogenic
3
2005
298
0.350
Why?
Proportional Hazards Models
10
2022
887
0.350
Why?
Cholangiocarcinoma
2
2005
57
0.340
Why?
Image Processing, Computer-Assisted
2
2012
1198
0.340
Why?
Tomography, Emission-Computed
1
2007
108
0.340
Why?
Life Style
4
2022
194
0.330
Why?
Medical Records Systems, Computerized
2
1999
42
0.330
Why?
Genotype
4
2020
1862
0.330
Why?
Tumor Suppressor Proteins
6
2022
283
0.320
Why?
Dietary Sucrose
2
2018
13
0.320
Why?
Sweetening Agents
2
2018
19
0.320
Why?
Thymidylate Synthase
2
2004
14
0.320
Why?
Nausea
6
2020
170
0.310
Why?
TOR Serine-Threonine Kinases
4
2016
184
0.310
Why?
Internet
2
1999
327
0.300
Why?
Genome-Wide Association Study
4
2021
1546
0.300
Why?
Practice Guidelines as Topic
3
2019
1095
0.290
Why?
Vitamin D
3
2018
265
0.290
Why?
Databases, Factual
3
2016
813
0.290
Why?
Proto-Oncogene Proteins c-met
3
2016
202
0.280
Why?
Indoles
6
2011
335
0.280
Why?
Heart Neoplasms
1
2005
65
0.270
Why?
Oligopeptides
1
2005
188
0.270
Why?
Sulfonamides
5
2019
333
0.270
Why?
Feasibility Studies
4
2016
770
0.270
Why?
Aorta, Thoracic
1
2005
175
0.260
Why?
United States
11
2021
6554
0.260
Why?
Hypertension
3
2021
1224
0.260
Why?
Artificial Intelligence
4
2005
219
0.260
Why?
Thoracic Surgical Procedures
3
2015
43
0.260
Why?
Protein-Tyrosine Kinases
2
2004
310
0.250
Why?
Drug Resistance, Neoplasm
6
2010
581
0.250
Why?
Boronic Acids
3
2010
55
0.250
Why?
Vomiting
4
2016
186
0.250
Why?
Young Adult
11
2020
6106
0.250
Why?
Gastrointestinal Stromal Tumors
2
2017
26
0.250
Why?
Receptor, IGF Type 1
2
2013
43
0.250
Why?
Albumins
2
2020
123
0.250
Why?
Mutation
7
2020
3901
0.240
Why?
Cohort Studies
6
2021
2764
0.240
Why?
Exercise
2
2018
290
0.240
Why?
Benzimidazoles
3
2020
137
0.240
Why?
Models, Theoretical
1
2006
494
0.240
Why?
Neurofibromin 2
2
2019
26
0.240
Why?
Magnetic Resonance Angiography
1
2005
257
0.240
Why?
Arthrogryposis
1
2022
7
0.240
Why?
Pilot Projects
4
2018
845
0.230
Why?
Clinical Trials, Phase III as Topic
5
2013
165
0.230
Why?
Nomograms
1
2022
25
0.230
Why?
Nucleic Acid Synthesis Inhibitors
1
2021
17
0.230
Why?
Cholestasis
1
2022
49
0.230
Why?
Kv1.3 Potassium Channel
1
2021
14
0.230
Why?
Risk Factors
10
2022
5513
0.230
Why?
Neoplasm Grading
2
2020
333
0.230
Why?
Photography
2
1998
35
0.220
Why?
Carcinoma, Non-Small-Cell Lung
5
2006
1003
0.220
Why?
Chicago
2
2020
1461
0.220
Why?
Renal Insufficiency
1
2022
113
0.220
Why?
Diagnosis, Computer-Assisted
3
2007
327
0.220
Why?
Beverages
2
2018
20
0.220
Why?
Proteinuria
1
2021
114
0.220
Why?
Antibodies, Bispecific
1
2021
18
0.210
Why?
Enzyme Inhibitors
2
2005
673
0.210
Why?
Income
1
2021
79
0.210
Why?
Diarrhea
4
2019
209
0.210
Why?
Observation
1
2020
39
0.210
Why?
Cell Line, Tumor
10
2018
2441
0.210
Why?
Risk Assessment
5
2019
2303
0.210
Why?
Genomics
2
2017
666
0.200
Why?
Niacinamide
2
2010
117
0.200
Why?
Uracil
1
2000
68
0.200
Why?
Information Storage and Retrieval
3
2005
122
0.200
Why?
Phenylurea Compounds
2
2010
110
0.200
Why?
Aminopterin
1
1999
5
0.200
Why?
Jews
1
2020
45
0.200
Why?
Genetic Predisposition to Disease
5
2022
2251
0.200
Why?
Oxidoreductases
1
2000
119
0.200
Why?
Bone Marrow
2
2007
425
0.200
Why?
Pharmaceutical Preparations
1
2021
93
0.200
Why?
Randomized Controlled Trials as Topic
6
2022
877
0.190
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2019
24
0.190
Why?
Cytidine Deaminase
1
2019
44
0.190
Why?
Neuroendocrine Tumors
2
2014
91
0.190
Why?
Universities
2
2010
137
0.190
Why?
Pancreatectomy
3
2016
155
0.190
Why?
Leukemia
2
2006
310
0.180
Why?
Pancreaticoduodenectomy
1
2019
85
0.180
Why?
Listeria monocytogenes
1
2019
89
0.180
Why?
Topotecan
1
1998
46
0.180
Why?
Phosphorylation
5
2018
1163
0.180
Why?
Nutrition Policy
1
2018
12
0.180
Why?
Nuts
1
2018
3
0.180
Why?
Oncogene Proteins, Fusion
1
2019
124
0.180
Why?
Palliative Care
3
2018
255
0.180
Why?
Organoids
1
2018
46
0.180
Why?
Seafood
1
2018
9
0.180
Why?
Focal Adhesion Kinase 1
1
2018
31
0.180
Why?
Multimedia
1
1998
7
0.180
Why?
Sarcopenia
1
2018
12
0.180
Why?
Radiodermatitis
1
1998
12
0.180
Why?
Neoplasm Proteins
2
2020
551
0.170
Why?
Hospital Information Systems
2
1997
8
0.170
Why?
Genetic Testing
2
2020
508
0.170
Why?
Melanoma
2
2022
520
0.170
Why?
Models, Statistical
1
2022
583
0.170
Why?
Radiosurgery
1
2021
270
0.170
Why?
Tumor Burden
3
2016
291
0.170
Why?
Receptor Protein-Tyrosine Kinases
2
2011
161
0.170
Why?
Reproducibility of Results
5
2012
2734
0.170
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2017
11
0.170
Why?
Fatty Acids, Omega-3
1
2018
56
0.170
Why?
Patient Compliance
2
2018
252
0.170
Why?
Management Information Systems
1
1997
3
0.170
Why?
Receptors, Calcitriol
1
2018
134
0.160
Why?
Computer Communication Networks
1
1997
24
0.160
Why?
Hematopoiesis
2
1995
160
0.160
Why?
Immunoglobulin G
2
2019
488
0.160
Why?
Skin Neoplasms
1
2022
548
0.160
Why?
Postoperative Care
1
2017
230
0.160
Why?
Time Factors
8
2021
5562
0.160
Why?
Skin Diseases
1
1998
164
0.160
Why?
Sex Factors
2
2019
1098
0.160
Why?
Veratrum Alkaloids
1
2016
12
0.160
Why?
CA-19-9 Antigen
1
2016
12
0.150
Why?
Documentation
1
1997
96
0.150
Why?
Fractals
1
2016
45
0.150
Why?
Decision Support Techniques
1
1998
164
0.150
Why?
Age Factors
2
2019
1934
0.150
Why?
Fishes
1
2018
142
0.150
Why?
Decision Making, Computer-Assisted
2
1995
13
0.150
Why?
Karnofsky Performance Status
1
2015
38
0.150
Why?
Coffee
1
2015
12
0.150
Why?
Class I Phosphatidylinositol 3-Kinases
1
2016
51
0.150
Why?
Academic Medical Centers
1
2019
393
0.150
Why?
Cone-Beam Computed Tomography
1
2016
63
0.150
Why?
Radiography, Thoracic
2
2011
325
0.150
Why?
Adolescent
4
2022
9329
0.150
Why?
Hypoglycemic Agents
1
2019
389
0.150
Why?
Disease Management
1
2018
343
0.140
Why?
Polymorphism, Genetic
1
2019
824
0.140
Why?
Mice
9
2018
11342
0.140
Why?
Hydroxamic Acids
1
2015
48
0.140
Why?
Cosmic Radiation
1
1994
1
0.140
Why?
Solar Activity
1
1994
1
0.140
Why?
Nervous System Diseases
1
2016
151
0.140
Why?
Evidence-Based Medicine
1
2018
457
0.140
Why?
Blood Cells
1
1994
36
0.140
Why?
Polyethylene Glycols
1
2017
397
0.140
Why?
Gamma Rays
1
1994
86
0.140
Why?
Protein Kinase C
2
2008
301
0.140
Why?
Immunotherapy
4
2020
600
0.130
Why?
Animals
18
2018
27415
0.130
Why?
Acute Disease
5
1999
877
0.130
Why?
Vascular Endothelial Growth Factor D
1
2013
2
0.130
Why?
Lymphatic Metastasis
3
2015
508
0.130
Why?
Chemokine CXCL12
1
2013
33
0.130
Why?
Chemoradiotherapy
1
2016
295
0.130
Why?
Carcinoma, Hepatocellular
2
2009
334
0.130
Why?
Vesicular Transport Proteins
1
2013
65
0.130
Why?
Odds Ratio
1
2015
694
0.130
Why?
Health Status
2
2015
370
0.130
Why?
Neoplasm Invasiveness
3
2017
536
0.130
Why?
Pattern Recognition, Automated
2
2005
225
0.120
Why?
Vitamin D Deficiency
1
2014
105
0.120
Why?
World Health Organization
3
1999
103
0.120
Why?
Insulin
1
2019
1174
0.120
Why?
Computer Simulation
1
1998
1074
0.120
Why?
Folic Acid
2
2003
49
0.120
Why?
Cell Movement
5
2018
756
0.120
Why?
Observer Variation
4
2013
622
0.120
Why?
Sensitivity and Specificity
4
2012
2093
0.120
Why?
Phosphotransferases (Alcohol Group Acceptor)
1
2012
87
0.120
Why?
Geriatric Assessment
1
2013
161
0.120
Why?
Thrombospondin 1
1
2011
22
0.120
Why?
Mitochondria
1
2016
538
0.120
Why?
Sirolimus
2
2014
173
0.120
Why?
Hyperthermia, Induced
1
2013
66
0.110
Why?
Tomography, Spiral Computed
2
2018
75
0.110
Why?
Carcinoma, Small Cell
2
2006
140
0.110
Why?
Multidetector Computed Tomography
1
2012
57
0.110
Why?
Pyrroles
2
2010
221
0.110
Why?
src-Family Kinases
1
2011
76
0.110
Why?
Pulmonary Atelectasis
1
2010
17
0.110
Why?
Osteopontin
1
2011
53
0.110
Why?
Interleukin-17
1
2011
96
0.110
Why?
Survivors
1
2013
217
0.110
Why?
Administration, Oral
7
2007
730
0.100
Why?
Histones
1
2012
310
0.100
Why?
Reference Standards
1
2010
149
0.100
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
118
0.100
Why?
Hepatocyte Growth Factor
2
2011
83
0.100
Why?
Proto-Oncogene Proteins p21(ras)
3
2018
146
0.100
Why?
Research Design
1
2013
588
0.090
Why?
Xenograft Model Antitumor Assays
3
2016
465
0.090
Why?
Protease Inhibitors
2
2010
74
0.090
Why?
National Cancer Institute (U.S.)
2
2019
68
0.090
Why?
Mice, Nude
3
2016
789
0.090
Why?
Alanine
2
2008
87
0.090
Why?
Pain
1
2011
375
0.090
Why?
Confidence Intervals
3
2021
236
0.090
Why?
Algorithms
3
2012
1858
0.090
Why?
Cancer Vaccines
2
2007
158
0.090
Why?
Quinoxalines
1
2008
56
0.090
Why?
DNA Repair
2
2021
352
0.090
Why?
Adenine
1
2008
88
0.090
Why?
Carcinoembryonic Antigen
1
2007
36
0.090
Why?
Dermatology
2
1998
35
0.090
Why?
Immunotoxins
1
2007
13
0.090
Why?
Glycolipids
1
2007
37
0.090
Why?
Models, Biological
2
1997
1799
0.090
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2008
102
0.080
Why?
Anus Neoplasms
1
2007
31
0.080
Why?
Morpholines
2
2016
80
0.080
Why?
Azacitidine
1
2008
123
0.080
Why?
Protein Kinases
1
2009
226
0.080
Why?
Consensus
2
2019
310
0.080
Why?
Imaging, Three-Dimensional
1
2012
586
0.080
Why?
Prevalence
3
2020
1289
0.080
Why?
Aortic Aneurysm
1
2007
81
0.080
Why?
Software
4
2012
657
0.080
Why?
Cell Proliferation
4
2016
1634
0.080
Why?
Hepatectomy
2
2007
158
0.080
Why?
Drug Synergism
3
2016
334
0.080
Why?
Fluorodeoxyglucose F18
1
2007
126
0.080
Why?
Aneurysm, Dissecting
1
2007
95
0.080
Why?
Tumor Microenvironment
2
2021
340
0.080
Why?
Radiopharmaceuticals
1
2007
179
0.080
Why?
Thrombocytopenia
5
2007
176
0.080
Why?
Liver Diseases
2
2007
230
0.080
Why?
Esophagogastric Junction
2
2010
33
0.080
Why?
Paronychia
1
2006
1
0.080
Why?
Wound Healing
5
2014
346
0.080
Why?
Glycoproteins
1
2007
254
0.080
Why?
Heterozygote
2
2018
376
0.080
Why?
Immunity, Cellular
2
2022
195
0.080
Why?
Doxycycline
1
2006
33
0.080
Why?
Neovascularization, Pathologic
2
2018
358
0.080
Why?
Fabry Disease
1
2005
5
0.070
Why?
alpha-Galactosidase
1
2005
5
0.070
Why?
Case-Control Studies
3
2019
1839
0.070
Why?
Depsipeptides
1
2005
30
0.070
Why?
Opportunistic Infections
1
2006
68
0.070
Why?
Carotid Artery, Common
1
2005
29
0.070
Why?
Drug Eruptions
1
2005
38
0.070
Why?
Subclavian Artery
1
2005
39
0.070
Why?
Prodrugs
2
2004
48
0.070
Why?
Receptor, trkA
1
2005
14
0.070
Why?
Meta-Analysis as Topic
1
2005
104
0.070
Why?
Feeding Behavior
2
2018
326
0.070
Why?
Proto-Oncogene Proteins c-raf
1
2004
50
0.070
Why?
Carbazoles
1
2005
53
0.070
Why?
Oligonucleotides, Antisense
1
2004
70
0.070
Why?
RNA, Messenger
3
2018
2023
0.070
Why?
Coronary Circulation
1
2005
139
0.070
Why?
Liposomes
1
2004
104
0.070
Why?
Vaccination
2
2022
257
0.070
Why?
Carcinoid Tumor
1
2004
44
0.070
Why?
Incidental Findings
1
2005
95
0.070
Why?
Comorbidity
1
2008
954
0.070
Why?
Myocardial Infarction
1
2007
381
0.070
Why?
Cyclosporine
1
2005
255
0.070
Why?
Pyrrolidines
1
2004
58
0.070
Why?
Remission Induction
1
2005
717
0.060
Why?
Coronary Disease
1
2005
307
0.060
Why?
Proto-Oncogene Proteins
3
2013
681
0.060
Why?
Hematinics
1
2003
10
0.060
Why?
DNA Methylation
1
2008
584
0.060
Why?
Kidney Diseases
1
2007
426
0.060
Why?
Treatment Failure
2
2004
307
0.060
Why?
Flavonoids
1
2003
84
0.060
Why?
High-Throughput Nucleotide Sequencing
2
2018
422
0.060
Why?
PTEN Phosphohydrolase
2
2014
124
0.060
Why?
Vitamin B 12
1
2002
19
0.060
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
2019
108
0.060
Why?
Granulation Tissue
3
1969
12
0.060
Why?
Radiotherapy
2
2006
342
0.060
Why?
Positron-Emission Tomography
2
2020
279
0.060
Why?
Antibody Formation
2
2022
214
0.060
Why?
Adrenal Insufficiency
1
2022
23
0.060
Why?
Marital Status
1
2022
42
0.060
Why?
DNA, Antisense
1
2002
17
0.060
Why?
Vaccines, Synthetic
1
2022
55
0.060
Why?
Drug Therapy, Combination
3
2018
1002
0.060
Why?
Infusions, Intra-Arterial
1
2001
34
0.060
Why?
Ascites
1
2022
57
0.060
Why?
Fatigue
2
2019
173
0.060
Why?
Epidemiologic Methods
1
2001
65
0.060
Why?
Anti-Bacterial Agents
2
2006
834
0.060
Why?
Apoptosis
3
2016
1783
0.060
Why?
Piperidines
1
2003
192
0.060
Why?
Multicenter Studies as Topic
1
2022
156
0.060
Why?
Hepatic Artery
1
2001
84
0.060
Why?
Vascular Cell Adhesion Molecule-1
1
2021
58
0.060
Why?
Image Enhancement
1
2005
584
0.050
Why?
Angiopoietin-2
1
2021
20
0.050
Why?
ras Proteins
2
2013
133
0.050
Why?
Microtubules
2
2016
116
0.050
Why?
France
1
2021
51
0.050
Why?
Isoenzymes
1
2002
276
0.050
Why?
Mitotic Index
1
2020
19
0.050
Why?
Radiotherapy, Intensity-Modulated
2
2016
182
0.050
Why?
Platinum Compounds
1
2020
31
0.050
Why?
Dihydrouracil Dehydrogenase (NADP)
1
2000
28
0.050
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2004
464
0.050
Why?
Programmed Cell Death 1 Receptor
1
2022
169
0.050
Why?
Israel
1
2020
59
0.050
Why?
Image Interpretation, Computer-Assisted
1
2005
672
0.050
Why?
Australia
1
2020
94
0.050
Why?
Severity of Illness Index
1
2006
1799
0.050
Why?
Antibodies, Viral
1
2022
348
0.050
Why?
T-Lymphocytes
2
2022
1317
0.050
Why?
Canada
1
2020
212
0.050
Why?
Constipation
1
2020
68
0.050
Why?
Acetals
1
1999
3
0.050
Why?
Thoracic Neoplasms
1
2019
60
0.050
Why?
Immunosuppressive Agents
1
2005
1030
0.050
Why?
Fibroblast Growth Factor 2
1
2019
70
0.050
Why?
Cell Cycle
2
2014
522
0.050
Why?
Child
1
2010
6956
0.050
Why?
Platinum
1
2019
58
0.050
Why?
International Cooperation
1
1999
135
0.050
Why?
Protein Methyltransferases
1
2018
14
0.050
Why?
NFATC Transcription Factors
1
2018
28
0.050
Why?
Infusion Pumps
1
1998
27
0.050
Why?
Topoisomerase I Inhibitors
1
1998
36
0.050
Why?
Down-Regulation
1
2020
527
0.050
Why?
Contrast Media
1
2004
1088
0.050
Why?
Area Under Curve
3
2004
346
0.050
Why?
Cyclophosphamide
1
2019
291
0.050
Why?
Heart Diseases
1
2001
315
0.050
Why?
Focal Adhesion Kinase 2
1
2018
11
0.040
Why?
Nutritive Value
1
2018
5
0.040
Why?
Diet Records
1
2018
21
0.040
Why?
Ukraine
1
1998
7
0.040
Why?
Power Plants
1
1998
5
0.040
Why?
Energy Intake
1
2018
99
0.040
Why?
Sulfones
1
2018
52
0.040
Why?
Cell Nucleus
1
2020
591
0.040
Why?
Multivariate Analysis
1
2021
1026
0.040
Why?
Quinolones
1
2018
57
0.040
Why?
Cyclooxygenase 2
1
2018
100
0.040
Why?
Ligands
1
2019
433
0.040
Why?
Up-Regulation
1
2020
717
0.040
Why?
Histone-Lysine N-Methyltransferase
1
2018
147
0.040
Why?
Antiemetics
1
1999
96
0.040
Why?
Patient Care Planning
1
1998
85
0.040
Why?
Illinois
1
2019
474
0.040
Why?
Health Services Accessibility
1
2021
411
0.040
Why?
Cost Control
1
1997
45
0.040
Why?
Recombinant Fusion Proteins
1
2019
570
0.040
Why?
Cell Culture Techniques
1
2018
202
0.040
Why?
Epithelioid Cells
1
2016
13
0.040
Why?
Patient Safety
1
2019
214
0.040
Why?
Efficiency, Organizational
1
1997
58
0.040
Why?
RNA, Small Interfering
2
2011
569
0.040
Why?
Drug Evaluation, Preclinical
2
2007
122
0.040
Why?
Aminopyridines
1
2016
30
0.040
Why?
Cell Adhesion
1
2018
432
0.040
Why?
Cell Cycle Checkpoints
1
2016
62
0.040
Why?
Anemia
3
2007
130
0.040
Why?
Risk
1
2018
707
0.040
Why?
Neoplasms, Experimental
1
2018
287
0.040
Why?
Immunohistochemistry
3
2012
1836
0.040
Why?
Radiography
2
2010
881
0.040
Why?
Tea
1
2015
16
0.040
Why?
Leukopenia
2
2007
65
0.040
Why?
Lymphokines
2
2002
115
0.040
Why?
Autoradiography
3
1967
77
0.040
Why?
Total Lung Capacity
1
2015
8
0.040
Why?
Neoplasm, Residual
1
2016
150
0.040
Why?
Glycolysis
1
2016
129
0.040
Why?
Alcohol Drinking
1
2018
276
0.040
Why?
Pyrazoles
1
2016
169
0.040
Why?
Space Flight
1
1994
6
0.040
Why?
Mitochondrial Proteins
1
2016
119
0.040
Why?
Bone Marrow Diseases
1
1995
42
0.040
Why?
Hemodynamics
2
2018
721
0.040
Why?
Recurrence
1
2018
1203
0.040
Why?
Pyrrolidinones
1
2014
17
0.040
Why?
Aerospace Medicine
1
1994
15
0.040
Why?
Organ Size
1
2016
390
0.030
Why?
Decision Trees
1
1995
69
0.030
Why?
Systems Integration
1
1995
40
0.030
Why?
Anthropometry
1
1995
79
0.030
Why?
Leukocyte Count
1
1995
225
0.030
Why?
Magnetic Resonance Imaging
2
2004
3319
0.030
Why?
cdc25 Phosphatases
1
2014
18
0.030
Why?
Metformin
1
2016
113
0.030
Why?
Mathematics
1
1994
191
0.030
Why?
Caffeine
1
2015
81
0.030
Why?
Probability
2
2007
363
0.030
Why?
Dose-Response Relationship, Radiation
1
1994
201
0.030
Why?
Body Mass Index
1
2018
794
0.030
Why?
Colon
1
2018
514
0.030
Why?
Educational Status
1
2014
180
0.030
Why?
Registries
1
2018
692
0.030
Why?
Genetic Counseling
1
2014
99
0.030
Why?
SEER Program
1
2014
205
0.030
Why?
Quinolines
1
2014
98
0.030
Why?
Education, Medical
1
1997
220
0.030
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2013
5
0.030
Why?
Mice, Transgenic
1
2018
1573
0.030
Why?
Radiation Tolerance
1
1994
175
0.030
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
23
0.030
Why?
Stomatitis
2
2004
30
0.030
Why?
Lung Volume Measurements
1
2013
20
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2014
249
0.030
Why?
Radiation Dosage
1
1994
231
0.030
Why?
Recovery of Function
1
2015
271
0.030
Why?
Diagnostic Errors
1
1995
170
0.030
Why?
Carcinoma, Squamous Cell
1
2000
1043
0.030
Why?
Dogs
1
1994
811
0.030
Why?
Incidence
1
2018
1668
0.030
Why?
Chromosome Aberrations
1
2014
400
0.030
Why?
Patient Selection
2
2013
709
0.030
Why?
Breast
1
1995
287
0.030
Why?
Insulin-Like Growth Factor I
1
2013
119
0.030
Why?
Acetylation
1
2012
122
0.030
Why?
Rats
4
1994
4363
0.030
Why?
Family
1
2014
315
0.030
Why?
Macrophage Colony-Stimulating Factor
1
2012
19
0.030
Why?
Chromatin Immunoprecipitation
1
2012
136
0.030
Why?
Tandem Mass Spectrometry
1
2012
99
0.030
Why?
Immunoblotting
1
2012
280
0.030
Why?
Peptide Fragments
1
2014
482
0.030
Why?
Bone Neoplasms
2
2010
329
0.030
Why?
Social Behavior
1
2015
296
0.030
Why?
alpha 1-Antichymotrypsin
1
2011
4
0.030
Why?
Medicare
1
2014
322
0.030
Why?
Proteins
3
1963
784
0.030
Why?
Chromosomal Instability
1
2011
20
0.030
Why?
Receptors, Growth Factor
1
2011
56
0.030
Why?
Ploidies
1
2011
37
0.030
Why?
STAT3 Transcription Factor
1
2011
72
0.030
Why?
Loss of Heterozygosity
1
2011
88
0.030
Why?
Liver
3
2004
1267
0.030
Why?
Neoplastic Cells, Circulating
1
2011
70
0.030
Why?
Psychometrics
1
2012
307
0.030
Why?
Gene Dosage
1
2011
216
0.030
Why?
Amino Acid Substitution
1
2011
360
0.030
Why?
In Situ Hybridization, Fluorescence
1
2011
362
0.030
Why?
Early Detection of Cancer
1
2014
362
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
1997
831
0.030
Why?
Linkage Disequilibrium
1
2011
485
0.020
Why?
Receptor, erbB-2
1
2011
193
0.020
Why?
Haptens
2
1988
9
0.020
Why?
Muscle, Skeletal
3
2004
449
0.020
Why?
Taxoids
1
2009
132
0.020
Why?
Mucositis
1
2009
22
0.020
Why?
Phorbol Esters
1
2008
30
0.020
Why?
Inhibitory Concentration 50
1
2008
64
0.020
Why?
Biopsy
1
2012
1196
0.020
Why?
Fibronectins
1
1988
95
0.020
Why?
Mitomycin
1
2007
36
0.020
Why?
Tritium
2
1967
141
0.020
Why?
Antibodies, Anti-Idiotypic
1
2007
53
0.020
Why?
Leucine
2
1967
69
0.020
Why?
Genes, Intracisternal A-Particle
1
2007
3
0.020
Why?
Drug Resistance, Multiple
1
2007
27
0.020
Why?
Liver Function Tests
1
2007
100
0.020
Why?
Phosphoproteins
1
2009
272
0.020
Why?
Pelvis
1
2007
85
0.020
Why?
Injections, Intravenous
1
2007
270
0.020
Why?
Obesity
1
1995
984
0.020
Why?
Cortisone
1
1967
11
0.020
Why?
Cell Line
1
2012
2627
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2007
82
0.020
Why?
NF-kappa B
1
2010
432
0.020
Why?
Kidney Function Tests
1
2007
133
0.020
Why?
Hydrocortisone
1
1969
304
0.020
Why?
Gastrectomy
1
2007
64
0.020
Why?
Clinical Trials, Phase I as Topic
2
1998
150
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2009
305
0.020
Why?
Radiotherapy Dosage
1
2007
485
0.020
Why?
Glucocorticoids
1
1969
364
0.020
Why?
African Americans
1
2014
1187
0.020
Why?
Mitogen-Activated Protein Kinase 3
1
2006
73
0.020
Why?
Mitogen-Activated Protein Kinase 1
1
2006
80
0.020
Why?
Cell Cycle Proteins
1
2009
387
0.020
Why?
Regression Analysis
1
2007
631
0.020
Why?
Cell Growth Processes
1
2006
83
0.020
Why?
Hyperemia
1
2005
22
0.020
Why?
Epidermal Growth Factor
1
2006
124
0.020
Why?
National Institutes of Health (U.S.)
1
2006
108
0.020
Why?
Polymerase Chain Reaction
1
2008
1003
0.020
Why?
Furans
1
2005
18
0.020
Why?
Microcirculation
1
2005
114
0.020
Why?
Avidin
1
1984
5
0.020
Why?
Phenylenediamines
1
2004
5
0.020
Why?
Mice, Inbred C57BL
1
2012
3259
0.020
Why?
Flow Cytometry
1
2007
733
0.020
Why?
Metabolic Clearance Rate
1
2004
128
0.020
Why?
Biotin
1
1984
46
0.020
Why?
Receptors, Endothelin
1
2004
13
0.020
Why?
Drug Interactions
1
2005
273
0.020
Why?
Transaminases
1
2004
36
0.020
Why?
Ovalbumin
1
1984
116
0.020
Why?
Numerical Analysis, Computer-Assisted
1
2004
32
0.020
Why?
Cell Survival
1
2007
1017
0.020
Why?
Histone Deacetylase Inhibitors
1
2004
81
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2006
320
0.020
Why?
Connective Tissue Cells
1
1963
3
0.020
Why?
Enzyme Activation
1
2006
740
0.020
Why?
Gene Transfer Techniques
1
2004
161
0.020
Why?
Connective Tissue
1
1963
27
0.020
Why?
Electrocardiography
1
2007
601
0.020
Why?
Neoplasm Transplantation
1
2004
401
0.020
Why?
Myocardial Ischemia
1
2005
173
0.020
Why?
Leukocytes, Mononuclear
1
2004
201
0.020
Why?
Skin Transplantation
1
1964
180
0.020
Why?
Gadolinium DTPA
1
2004
264
0.020
Why?
Cluster Analysis
1
2004
374
0.020
Why?
Signal Processing, Computer-Assisted
1
2004
211
0.020
Why?
Diagnosis, Differential
1
2007
1613
0.020
Why?
Quality Assurance, Health Care
1
2004
230
0.010
Why?
Societies, Medical
1
2006
580
0.010
Why?
Protein Kinase C-alpha
1
2002
30
0.010
Why?
Gene Expression Regulation, Neoplastic
1
2008
1212
0.010
Why?
Vascular Endothelial Growth Factors
1
2002
62
0.010
Why?
Razoxane
1
2001
2
0.010
Why?
Research
1
1963
267
0.010
Why?
Thionucleotides
1
2002
59
0.010
Why?
Endothelial Growth Factors
1
2002
60
0.010
Why?
Oxonic Acid
1
2001
8
0.010
Why?
Tegafur
1
2001
17
0.010
Why?
Oligonucleotides
1
2002
96
0.010
Why?
Radiographic Image Enhancement
1
2004
467
0.010
Why?
Interferons
1
2002
133
0.010
Why?
Base Sequence
1
2006
2425
0.010
Why?
Drug Combinations
1
2001
245
0.010
Why?
Doxorubicin
1
2001
299
0.010
Why?
Adjuvants, Immunologic
1
2002
171
0.010
Why?
Muscles
2
1952
194
0.010
Why?
Carcinoma
1
2004
444
0.010
Why?
Phenotype
1
2007
2334
0.010
Why?
Fibroblasts
1
1963
732
0.010
Why?
Antigen Presentation
1
2002
225
0.010
Why?
Immunologic Factors
1
2002
164
0.010
Why?
Molecular Sequence Data
1
2006
3191
0.010
Why?
Electrophoresis, Paper
1
1959
2
0.010
Why?
Knee
1
1959
20
0.010
Why?
Perfusion
3
1969
190
0.010
Why?
Antigens, Neoplasm
1
2002
335
0.010
Why?
Granisetron
1
1999
8
0.010
Why?
Blood Proteins
1
1959
160
0.010
Why?
Appendicitis
1
1959
60
0.010
Why?
Serotonin Antagonists
1
1999
40
0.010
Why?
Cost-Benefit Analysis
1
2001
454
0.010
Why?
Antibiotics, Antitubercular
1
1958
4
0.010
Why?
Knee Joint
1
1959
166
0.010
Why?
Osteomyelitis
1
1958
54
0.010
Why?
Cytokines
1
2002
780
0.010
Why?
Triazines
1
1997
48
0.010
Why?
Dermatologic Agents
1
1958
69
0.010
Why?
Dexamethasone
1
1999
324
0.010
Why?
Growth Substances
1
1997
88
0.010
Why?
Radiometry
1
1997
50
0.010
Why?
Databases as Topic
1
1997
94
0.010
Why?
Empyema, Pleural
1
1956
8
0.010
Why?
Empyema
1
1956
12
0.010
Why?
Clinical Trials, Phase II as Topic
1
1997
175
0.010
Why?
Pheochromocytoma
1
1956
66
0.010
Why?
Syndrome
1
1997
437
0.010
Why?
Patient Satisfaction
1
1999
447
0.010
Why?
Bone Cysts
1
1955
8
0.010
Why?
Giant Cell Tumors
1
1955
3
0.010
Why?
Cysts
1
1955
101
0.010
Why?
Switzerland
1
1973
15
0.010
Why?
Education, Nursing, Continuing
1
1973
8
0.010
Why?
Prostatic Neoplasms
1
2004
1603
0.010
Why?
Liver Circulation
2
1969
31
0.010
Why?
Hepatic Encephalopathy
2
1969
30
0.010
Why?
Foot Deformities
1
1952
6
0.010
Why?
Flatfoot
1
1952
7
0.010
Why?
Teaching
1
1973
143
0.010
Why?
Foot
1
1952
53
0.010
Why?
Leg
1
1952
137
0.010
Why?
Knee Dislocation
1
1951
3
0.010
Why?
Patellar Dislocation
1
1951
9
0.010
Why?
Relaxation
1
1950
1
0.010
Why?
Knee Injuries
1
1951
52
0.010
Why?
Learning
1
1973
269
0.010
Why?
Depression, Chemical
1
1969
33
0.010
Why?
Assisted Circulation
1
1969
14
0.010
Why?
Cell-Free System
1
1988
55
0.010
Why?
Cell Fractionation
1
1988
74
0.010
Why?
Gelatin
1
1988
25
0.010
Why?
Clone Cells
1
1988
305
0.010
Why?
Heparin
1
1988
189
0.010
Why?
Dinitrobenzenes
1
1984
5
0.000
Why?
Binding, Competitive
1
1984
176
0.000
Why?
Macromolecular Substances
1
1984
184
0.000
Why?
Mice, Inbred Strains
1
1984
335
0.000
Why?
Lysine
1
1984
149
0.000
Why?
Enzyme-Linked Immunosorbent Assay
1
1984
414
0.000
Why?
Swine
3
1969
585
0.000
Why?
Cells, Cultured
1
1988
2992
0.000
Why?
Peptides
1
1984
646
0.000
Why?
Bile
2
1969
65
0.000
Why?
Sulfobromophthalein
1
1969
1
0.000
Why?
Exchange Transfusion, Whole Blood
1
1969
18
0.000
Why?
Extracorporeal Circulation
1
1969
26
0.000
Why?
Methods
1
1969
186
0.000
Why?
Hematocrit
1
1969
78
0.000
Why?
Electrolytes
1
1969
60
0.000
Why?
L-Lactate Dehydrogenase
1
1969
68
0.000
Why?
Aspartate Aminotransferases
1
1969
72
0.000
Why?
Alanine Transaminase
1
1969
79
0.000
Why?
Bicarbonates
1
1969
71
0.000
Why?
Alkaline Phosphatase
1
1969
139
0.000
Why?
Bilirubin
1
1969
129
0.000
Why?
Hemoglobins
1
1969
178
0.000
Why?
Hydrogen-Ion Concentration
1
1969
557
0.000
Why?
Oxygen
1
1969
740
0.000
Why?
Kindler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_